| Shametra Lashelle Matthews, | |
|
601 Foote St, Corinth, MS 38834-4834 | |
| (662) 287-4424 | |
| (662) 287-2070 |
| Full Name | Shametra Lashelle Matthews |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 601 Foote St, Corinth, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164775516 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shametra Lashelle Matthews, Po Box 839, Corinth, MS 38835-0839 Ph: (662) 286-9883 | Shametra Lashelle Matthews, 601 Foote St, Corinth, MS 38834-4834 Ph: (662) 287-4424 |
News Archive
As food consumed in the U.S. becomes more and more processed, obesity may become more prevalent.
In by far the majority of cancer cases, the doctor can quickly identify the source of the disease, for example cancer of the liver, lungs, etc. However, in about one in 20 cases, the doctor can confirm that the patient has cancer—but cannot find the source. These patients then face the prospect of a long wait with numerous diagnostic tests and attempts to locate the origin of the cancer before starting any treatment.
Deep brain stimulation (DBS) of the ventral striatum/anterior limb of the internal capsule is safe and feasible in addressing the affective component of pain in patients with post-stroke pain syndrome.
The interaction between nicotine and alcohol, two of the most abused and co-abused drugs, can impact a person's ability to learn and could have implications for treating addiction, according to researchers at Temple University.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 2 days ago
Ashley L Saulter, PCMHT, NCE Counselor Medicare: Not Enrolled in Medicare Practice Location: 311 South Cass Street, Corinth, MS 38834 Phone: 662-286-2152 Fax: 662-286-8095 | |
Thomas Wilson Harington, Counselor Medicare: Not Enrolled in Medicare Practice Location: 601 Foote St, Corinth, MS 38834 Phone: 662-287-4424 Fax: 662-287-2070 | |
Latoya Yvette Cobbs, PCCMP Counselor Medicare: Not Enrolled in Medicare Practice Location: 2664 S Harper Rd, Corinth, MS 38834 Phone: 662-287-4055 Fax: 662-287-4114 | |
Ida Pat Patterson, PCMHT Counselor Medicare: Not Enrolled in Medicare Practice Location: 601 Foote St, Corinth, MS 38834 Phone: 662-287-4424 Fax: 662-286-8095 | |
Tammy Robertson, CMHT Counselor Medicare: Not Enrolled in Medicare Practice Location: 104 New Hope Road, Corinth, MS 38834 Phone: 662-287-7199 Fax: 662-286-8095 | |
Ladonna Pybus, Counselor Medicare: Not Enrolled in Medicare Practice Location: 806 S Parkway St, Corinth, MS 38834 Phone: 662-536-6210 | |
Audrey Hector, Counselor Medicare: Not Enrolled in Medicare Practice Location: 601 Foote St, Corinth, MS 38834 Phone: 662-287-4424 Fax: 662-287-2070 |